ACR适宜性标准®:浸润性乳腺癌的影像学检查
美国放射学会适宜性标准基于证据与专家小组评审,针对浸润性乳腺癌的分期与监测提出影像检查推荐:无症状根治性治疗后患者无需影像筛查远处复发;建议每年2-D乳腺X线摄影和/或断层合成用于监测乳房内复发或新原发癌;MRI作为额外筛查工具越来越多用于该人群,尤其致密乳腺女性。
要点
- 无症状根治性治疗后患者不推荐影像筛查远处复发。
- 有乳腺癌史女性建议每年2-D乳腺X线摄影和/或断层合成监测乳房内复发或新原发癌。
- MRI作为额外筛查工具越来越多用于该人群,尤其致密乳腺女性。
核心结论
- 浸润性乳腺癌影像用于分期和监测应基于证据指南,避免不必要影像延误治疗或导致不良结局。
- 无症状根治性治疗后患者无影像筛查远处复发的指征。
- 有乳腺癌史女性推荐每年2-D乳腺X线摄影和/或断层合成监测乳房内复发或新原发癌。
- MRI作为额外筛查工具越来越多用于该人群,尤其致密乳腺女性。
研究设计与样本
- 美国放射学会适宜性标准由多学科专家小组每年评审,基于同行评议文献系统分析制定。
- 采用GRADE等既定方法学原则评估证据,采用RAND/UCLA适宜性方法学确定特定临床场景影像与治疗程序的适宜性。
- 同行评议文献缺乏或模棱两可时,专家可作为主要证据来源形成推荐。
诊断标准与关键数值
- 无症状根治性治疗后患者:无影像筛查远处复发的指征。
- 有乳腺癌史女性:推荐每年2-D乳腺X线摄影和/或断层合成监测乳房内复发或新原发癌。
- MRI作为额外筛查工具越来越多用于该人群,尤其致密乳腺女性。
临床应用与阅片要点
- 评估浸润性乳腺癌分期与监测时,应依据证据指南确定影像指征。
- 避免不必要的影像检查,因其可能延误治疗甚至导致不良结局。
- 对无症状根治性治疗后患者,不应以影像筛查远处复发。
- 对有乳腺癌史女性,采用每年2-D乳腺X线摄影和/或断层合成监测乳房内复发或新原发癌。
- MRI作为额外筛查工具越来越多用于有乳腺癌史女性,尤其致密乳腺女性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
As the proportion of women diagnosed with invasive breast cancer increases, the role of imaging for staging and surveillance purposes should be determined based on evidence-based guidelines. It is important to understand the indications for extent of disease evaluation and staging, as unnecessary imaging can delay care and even result in adverse outcomes. In asymptomatic patients that received treatment for curative intent, there is no role for imaging to screen for distant recurrence. Routine surveillance with an annual 2-D mammogram and/or tomosynthesis is recommended to detect an in-breast recurrence or a new primary breast cancer in women with a history of breast cancer, and MRI is increasingly used as an additional screening tool in this population, especially in women with dense breasts. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
引用
- McDonald ES, Scheel JR, Lewin AA, et al. ACR Appropriateness Criteria® Imaging of Invasive Breast Cancer. J Am Coll Radiol. 2024. PMID: 38823943. doi:10.1016/j.jacr.2024.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。